scorecardresearch
Add as a preferred source on Google
Sunday, November 23, 2025
TopicIndian drugmaker

Topic: Indian drugmaker

Indian pharmas improved USFDA compliance, but cases of contamination grew 2014-2024—McKinsey report

The report, released at Global Pharmaceutical Quality Summit in Mumbai, draws comparison of incidences of ‘official action indicated' after USFDA inspections a decade apart.

Tax doctors on research grants by drugmakers, says govt panel reviewing pharma marketing practices

Five-member panel suggests doctors can't be given brand reminders exceeding Rs 1,000 each, Uniform Code of Pharmaceutical Marketing Practices to remain voluntary, but strengthened.

Sun Pharmaceutical flags revenue drop in its businesses due to ‘IT security incident’

The incident’s effect included breach of certain file systems and theft of some company and personal data, Sun Pharma said in a filing on Sunday.

On Camera

Taliban is gambling for strategic autonomy. Will Iran, China fill the Pakistan-sized hole?

Cutting trade ties with Pakistan is easier said than done: the neighbouring country is Afghanistan’s largest single trading partner, taking in 45 per cent of Afghan exports in 2024.

At Charcha 2025: Local entrepreneurship, not just big IT, will drive next wave of distributed AI work

While global corporations setting up GCCs in India continue to express confidence in availability of skilled AI engineers, the panel argued that India’s real challenge lies elsewhere.

From a small Kangra village to Tejas cockpit: IAF fighter pilot Namansh Syal’s journey cut short

Wing Commander Namansh Syal is survived by his wife, their 6-year-old daughter and his mother. Back in his native village, relatives and neighbours wait for his remains for last rites.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.